Clinical Trials in New York

Showing 2541-2560 of 19,464 trials

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

NCT06835972

The researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with metastatic clear cell renal cell carcinoma (ccRCC) and translocation-associated renal cell cancer (tRCC). The researchers will test different doses of the study drugs to find the highest doses that cause few or mild side effects in participants.

Metastatic Renal Cell CarcinomaTranslocation Renal Cell Carcinoma

Memorial Sloan Kettering Cancer Center43 participantsStarted Feb 2025

Baltimore, Maryland, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +5 more locations

Not Yet RecruitingPhase 2< 1 mile

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

NCT06705478

A phase II, randomized, open-label, two-arm clinical trial evaluating the safety and efficacy of pramipexole extended release (ER) versus escitalopram for the treatment of major depressive disorder (MDD) and comorbid MDD with mild neurocognitive disorder (MND) in persons with HIV (PWH). Participants will be assessed comprehensively and briefly at intercurrent visits to monitor for toxicity, response to therapy, and to assess for dose changes. An optional sub-study to evaluate treatment impact on the cerebrospinal fluid (CSF) profile will be conducted in a subset of 36 participants.

Major Depressive DisorderMild Neurocognitive DisorderHIV

National Institute of Allergy and Infectious Diseases (NIAID)186 participantsStarted Feb 2026

Birmingham, Alabama, United States • Los Angeles, California, United States • San Diego, California, United States +37 more locations

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Find Trials by Condition in New York

Stress Phenotypes and Preterm Birth

Evaluation of Circadian OS Technology on Melatonin Suppression

Assessment of CCM in HF With Higher Ejection Fraction

Moms and Babies Health and Well-being

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

BD SiteRite(TM) 9 Ultrasound System - Clinical Study

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Evaluating the Safety and Clinical Efficacy of the BAIBYS™ System in Intracytoplasmic Sperm Injection (ICSI)

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

Harm Reduction for Smokers With Mental Illness

Prostate Active Surveillance Study

A Study of Cytisinicline for Smoking Cessation in Adult Smokers

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)